Lionco Pharmaceutical Group Co. Ltd. operates as a pharmaceutical company. Lionco is engaged in the research, development, production and sales of pharmaceutical drugs.

Announcement on No Downward Revision of Conversion Price of ""Lionco Convertible Bonds"

Announcement on Engagement of Audit Institution for 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lionco Pharmaceutical Grou-A (603669 CH)

Announcement on No Downward Revision of Conversion Price of ""Lionco Convertible Bonds"

Announcement on Engagement of Audit Institution for 2025

Announcement on Resolutions of the 3rd Meeting of the 5th Board of Directors

Indicative Announcement on Expected Satisfaction of Conversion Price Correction Conditions for ""Lionco Convertible Bonds"

Notice on Convening the 3rd Extraordinary General Meeting in 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)